Electromed (NYSE:ELMD) Announces Quarterly Earnings Results

Electromed (NYSE:ELMD) issued its quarterly earnings data on Tuesday. The company reported $0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.14 by $0.06, Zacks reports. Electromed had a net margin of 8.14% and a return on equity of 10.97%. The company had revenue of $14.83 million during the quarter.

Electromed Trading Down 5.5 %

ELMD stock opened at $15.16 on Thursday. Electromed has a twelve month low of $9.53 and a twelve month high of $18.60. The company has a market capitalization of $131.22 million, a P/E ratio of 30.32 and a beta of 0.25. The firm has a 50 day simple moving average of $14.97 and a 200-day simple moving average of $15.41.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised shares of Electromed from a “buy” rating to a “strong-buy” rating in a research report on Monday, May 13th.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function.